SSY GROUP (02005.HK): Calcium Chloride API Approved for Registration by NMPA
NewTimeSpace: SSY Group Limited (02005.HK) announced that its calcium chloride has been approved by the National Medical Products Administration (NMPA) of China for registration as an active pharmaceutical ingredient (API) for use in marketed finished products.Calcium chloride is mainly indicated for the treatment of calcium deficiency, tetany and other conditions.
NewTimeSpace： SSY Group Limited (02005.HK) issued a voluntary announcement on March 19, stating that its calcium chloride has been approved by the NMPA for registration as an active pharmaceutical ingredient (API) for use in marketed finished products.
As an additive for intravenous injection solutions, calcium chloride is mainly used for the treatment of calcium deficiency, tetany, vitamin D deficiency and allergic diseases.
It is also applied to the rescue of magnesium poisoning, fluorine poisoning, and cardiac dysfunctions caused by hyperkalemia, hypocalcemia or calcium channel blockade.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
Tags：
- SSY GROUP (02005.HK): Vitamin K1 Injection obtains NMPA drug production registration certificate, deemed to pass consistency evaluation
- SSY GROUP (02005.HK): Four Products Receive NMPA Drug Manufacturing Registration Approvals, Deepening Infusion Therapy and Ophthalmology Portfolio
- SSY Group (02005.HK): All 16 Specifications of 13 Pharmaceutical Varieties Proposed to Be Selected in the 12th National Centralized Drug Procurement
- SSY Group (02005.HK): Cimetidine Injection and Acetylcysteine Solution for Inhalation Obtain Manufacturing Registration Approvals
- SSY GROUP (02005.HK): Four Products Obtain NMPA Manufacturing Registration Approvals, All Deemed to Have Passed Consistency Evaluation
